Heron Therapeuti Stock Market Value
| HRTX Stock | USD 2.26 0.05 2.16% |
| Symbol | Heron |
Heron Therapeuti Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Heron Therapeuti. If investors know Heron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Heron Therapeuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.09) | Revenue Per Share | Quarterly Revenue Growth 0.191 | Return On Assets | Return On Equity |
The market value of Heron Therapeuti is measured differently than its book value, which is the value of Heron that is recorded on the company's balance sheet. Investors also form their own opinion of Heron Therapeuti's value that differs from its market value or its book value, called intrinsic value, which is Heron Therapeuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Heron Therapeuti's market value can be influenced by many factors that don't directly affect Heron Therapeuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Heron Therapeuti's value and its price as these two are different measures arrived at by different means. Investors typically determine if Heron Therapeuti is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Heron Therapeuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Heron Therapeuti 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Heron Therapeuti's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Heron Therapeuti.
| 12/29/2024 |
| 03/29/2025 |
If you would invest 0.00 in Heron Therapeuti on December 29, 2024 and sell it all today you would earn a total of 0.00 from holding Heron Therapeuti or generate 0.0% return on investment in Heron Therapeuti over 90 days. Heron Therapeuti is related to or competes with Mereo BioPharma, Terns Pharmaceuticals, PDS Biotechnology, Inozyme Pharma, Hookipa Pharma, X4 Pharmaceuticals, and Acumen Pharmaceuticals. Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs More
Heron Therapeuti Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Heron Therapeuti's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Heron Therapeuti upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.93 | |||
| Information Ratio | 0.1347 | |||
| Maximum Drawdown | 29.8 | |||
| Value At Risk | (5.88) | |||
| Potential Upside | 7.98 |
Heron Therapeuti Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Heron Therapeuti's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Heron Therapeuti's standard deviation. In reality, there are many statistical measures that can use Heron Therapeuti historical prices to predict the future Heron Therapeuti's volatility.| Risk Adjusted Performance | 0.1169 | |||
| Jensen Alpha | 0.7306 | |||
| Total Risk Alpha | 1.0 | |||
| Sortino Ratio | 0.1838 | |||
| Treynor Ratio | 0.572 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Heron Therapeuti's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Heron Therapeuti Backtested Returns
Heron Therapeuti appears to be very risky, given 3 months investment horizon. Heron Therapeuti holds Efficiency (Sharpe) Ratio of 0.15, which attests that the entity had a 0.15 % return per unit of risk over the last 3 months. By evaluating Heron Therapeuti's technical indicators, you can evaluate if the expected return of 0.81% is justified by implied risk. Please utilize Heron Therapeuti's Risk Adjusted Performance of 0.1169, downside deviation of 3.93, and Market Risk Adjusted Performance of 0.582 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Heron Therapeuti holds a performance score of 11. The company retains a Market Volatility (i.e., Beta) of 1.17, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Heron Therapeuti will likely underperform. Please check Heron Therapeuti's potential upside, as well as the relationship between the accumulation distribution and period momentum indicator , to make a quick decision on whether Heron Therapeuti's current trending patterns will revert.
Auto-correlation | 0.54 |
Modest predictability
Heron Therapeuti has modest predictability. Overlapping area represents the amount of predictability between Heron Therapeuti time series from 29th of December 2024 to 12th of February 2025 and 12th of February 2025 to 29th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Heron Therapeuti price movement. The serial correlation of 0.54 indicates that about 54.0% of current Heron Therapeuti price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.54 | |
| Spearman Rank Test | 0.54 | |
| Residual Average | 0.0 | |
| Price Variance | 0.1 |
Heron Therapeuti lagged returns against current returns
Autocorrelation, which is Heron Therapeuti stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Heron Therapeuti's stock expected returns. We can calculate the autocorrelation of Heron Therapeuti returns to help us make a trade decision. For example, suppose you find that Heron Therapeuti has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Heron Therapeuti regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Heron Therapeuti stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Heron Therapeuti stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Heron Therapeuti stock over time.
Current vs Lagged Prices |
| Timeline |
Heron Therapeuti Lagged Returns
When evaluating Heron Therapeuti's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Heron Therapeuti stock have on its future price. Heron Therapeuti autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Heron Therapeuti autocorrelation shows the relationship between Heron Therapeuti stock current value and its past values and can show if there is a momentum factor associated with investing in Heron Therapeuti.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for Heron Stock Analysis
When running Heron Therapeuti's price analysis, check to measure Heron Therapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heron Therapeuti is operating at the current time. Most of Heron Therapeuti's value examination focuses on studying past and present price action to predict the probability of Heron Therapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heron Therapeuti's price. Additionally, you may evaluate how the addition of Heron Therapeuti to your portfolios can decrease your overall portfolio volatility.